Stabilization of alum-adjuvanted vaccine dry powder formulations: Mechanism and application

Journal of Pharmaceutical Sciences

Volumn 92, Issue 2, 2003, Pages 319-332

  Maa, Yuh Fun ^a,b   Zhao, Lu ^a,c   Payne, Lendon G ^a   Chen, Dexiang ^a  

^a PowderJect Vaccines Inc   (United States)

^b ALZA CORPORATION   (United States)

^c NEKTAR THERAPEUTICS   (United States)

Author keywords

Alum gel coagulation; Diphtheria and tetanus toxoids; Epidermal powder immunization; Freeze drying; Hepatitis B vaccine; Spray drying; Spray freeze drying

Indexed keywords

ALUMINUM HYDROXIDE; DIPHTHERIA TETANUS TOXOID; HEPATITIS B VACCINE; VACCINE;

ARTICLE; DRUG FORMULATION; DRUG STABILITY; DRY POWDER; FREEZE DRYING; IMMUNOGENICITY; MICROSCOPY; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; SPRAY DRYING;

EID: 0037308432     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10294     Document Type: Article

References (21)

1. Warren HS, Vogel FR, Chedid LA. 1986. Current status of immunological adjuvants. Annu Rev Immunol 4:369-388.
2. Alving CR, Detrick B, Richards RL, Lewis MG, Shafferman A, Eddy GA. 1993. Novel adjuvant strategies for experiment malaria and AIDS vaccines. Ann NY Acad Sci 690:265-275.
3. Zapata MI, Feldkamp JR, Peck GE, White JL, Hem SL. 1984. Mechanism of freeze-thaw instability of aluminum hydroxycarbonate and magnesium hydroxide gels. J Pharm Sci 73:3-8.
4. Diminsky D, Moav N, Gorecki M, Barenholz Y. 1999. Physical, chemical, and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 18:3-17.
5. Menon PS, Sahai G, Joshi VB, Murthy RGS, Boparai MS, Thomas AK. 1976. Field trial on frozen and thawed tetanus toxoid. Indian J Med Res 64: 25-32.
6. Rethy L, Solyom F, Bacskai L, Geresi M, Gerhardt Z, Koves B, Kriston K, Magyar T, Masek I, Nagy B, Nemesi M. 1985. Design and control of new type vaccines. Efficacy testing of adsorbed and freeze-dried toxoid-virus-bacterium combined vaccines. Ann Immunol Hung 25:49-57.
7. Kyosuke M, Yoshimitsu I, Tetsuo K, Nobuya O. 1989. Hepatitis B vaccine and method for its preparation. Eur Pat #0130619.
8. Csizer Z, Sikos K, Bacskai L, Niedermayer E, Rethy L, Zsidai J. 1986. Process for the preparation of lyophilized, adsorbed polyvalent vaccines. U.S. Pat. #4,578,270.
9. Cooper JC, Sparks RE, Jacobs IC, Mason NS. 1999. Spray dried vaccine preparation comprising aluminum adsorbed immunogens. U.S. Pat #5,902,565.
10. Gupta RK, Rost BE, Relyveld E, Siber GR. 1995. Adjuvant properties of aluminum and calcium compounds. In: Powell MF, Newman MJ, editors. Vaccine design: The subunit and adjuvant approach. New York: Plenum Press. pp 229-248.
11. Adamson AW. 1976. Physical chemistry of surfaces, 3rd ed. New York: Wiley. pp 372-384.
12. Maa Y-F, Nguyen PA, Sweeney T, Shire SJ, Hsu CC. 1999. Protein inhalation powder: Spray drying vs. spray freeze drying. Pharm Res 16:249-254.
13. Maa Y-F, Nguyen PA. 2001. Method of spray freeze drying proteins for pharmaceutical administration. U.S. Pat #6,282,282.
14. Maa Y-F, Prestrelski S. 2000. Biopharmaceutical powders: Particle formation and formulation considerations. Curr Pharmaceut Biotechnol 1:283-302.
15. Chen D, Endres RL, Erickson CA, Weis KF, McGregor RW, Kawaoka Y, Payne LG. 2000. Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice. Nat Med 6:1187-1190.
16. Chen D, Erickson CA, Endres RL, Periwal SB, Chu Q, Shu C, Maa Y-F, Payne LG. 2001. Adjuvantation of epidermal powder immunization. Vaccine 19:2908-2917.
17. Flohe SB, Bauer C, Moll H. 1998. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur J Immunol 28:3800.
18. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. 1997. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2:1122.
19. Polillio AM, Kiley J. 1997. Does a needleless injection system reduce anxiety in children receiving intramuscular injections? Pediatr Nurs 23:46.
20. Shalaby WS. 1995. Development of oral vaccines to stimulate mucosal and systemic immunity: Barriers and novel strategies. Clin Immunol Immunopathol 74:127-134.
21. Freytag LC, Clements JD. 1999. Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 236:215.